Advertisement

Advertisement

42nd Annual Chemotherapy Foundation Symposium

breast cancer

Tiffany Traina, MD, FASCO, on Advances in the Treatment of HR-Positive Breast Cancer

Tiffany Traina, MD, FASCO, is Vice Chair of the Department of Medicine at Memorial Sloan Kettering Cancer Center, where she has been a medical oncologist on the Breast Medicine Service since 2006. Dr....

breast cancer

Komal Jhaveri, MD, FACP, on Antibody-Drug Conjugates in Breast Cancer

Komal Jhaveri, MD, FACP, is an Associate Professor of Clinical Medicine at Weill Cornell Medical College and a Breast Medical Oncologist & Early Drug Development Specialist at Memorial Sloan Kette...

breast cancer

Vered Stearns, MD, on Shifting Patient Outcomes: Updates in Triple-Negative Breast Cancer

Vered Stearns, MD, is the Director for Translational Breast Cancer Research in the Department of Hematology and Medical Oncology at Sandra and Edward Meyer Cancer Center and Weill Cornell Medical Scho...

Advertisement

Advertisement




Advertisement